Abstract: A vancomycin-resistant Lactococcus lactis isolate 1A-1 from a competitive exclusion (CE) product contained plasmid-encoded vanA, B, C1, and C2/3 genes. The L. lactis 1A-1 conjugatively transferred the genes to Staphylococcus aureus in vitro. CE product bacteria may be reservoirs for dissemination of vanA, B, and C genes to the human gastrointestinal microbiota.
INTRODUCTION
Vancomycin is a drug of last resort against antibioticresistant enterococci and methicillin-resistant staphylococci. Unfortunately, resistance to vancomycin is increasingly being reported [1, 2] . Studies on the dissemination and selection of antimicrobial drug resistance have focused mainly on clinically relevant bacterial species, but commensal bacteria may act as reservoirs of antimicrobial drug resistance genes similar to those found in human pathogens [3] . The commensal reservoir bacteria can be present in the intestines of farm animals exposed to antimicrobial drugs [4] , and subsequently may contaminate the raw meat produced from these animals. Therefore, antimicrobial drug resistance genes from non-pathogenic as well as from pathogenic organisms are medically important.
Competitive exclusion (CE) products are mixtures of bacteria that are applied to newly hatched poultry chicks for rapid establishment of a protective gastrointestinal (GI) tract microbiota, which can impart colonization resistance against the human food-borne pathogens Salmonella enterica and Campylobacter jejuni [5] . A CE product may be manufactured by anaerobic culture of the bacterial mixture in large fermentation batches. During the growth phase of the bacteria, they can come into contact with other species in the mixture. If conjugation occurs between these bacterial species, genes could be transferred from one to another. A Lactococcus lactis strain 1A-1 was isolated from a CE product that was resistant to vancomycin [6] , which is atypical of the species [7] . It is possible that the L. lactis isolate acquired a vancomycin resistance gene from a vancomycin-resistant Enterococcus sp. that was present in the CE product [8] . In the present study, we hypothesize that the vancomycinresistant L. lactis isolate may have the potential to transfer resistance determinants to a S. aureus strain similar to those that normally transit the human GI tract [9] . The present *Address correspondence to this author at the Division of Microbiology, National Center for Toxicological Research, HFT-250, 3900 NCTR Rd., Jefferson, AR 72022, USA; Tel: (870) 543-7434; Fax: (870) 543-7307; E-mail: doug.wagner@fda.hhs.gov study was conducted to identify the vancomycin resistance genes present in the L. lactis isolate. The ability of the L. lactis isolate to transfer vancomycin resistance genes by conjugation to S. aureus was also evaluated.
MATERIALS AND METHODS

Bacterial Strains and Growth Conditions
The vancomycin-resistant L. lactis gene donor and S. aureus transconjugants were grown at 30ºC in MRS broth (Thermo Fisher Scientific, Houston, TX) supplemented with 30 μg/ml vancomycin (Sigma Chemical Co., St. Louis, MO) or in Elliker broth (Thermo Fisher) containing various concentrations of vancomycin at 30°C. Chemically competent E. coli (Invitrogen, Grand Island, NY) was grown at 37ºC in Luria Bertani (LB) broth (Invitrogen). S. aureus ATCC 25923 was grown at 37ºC in MRS broth.
Phenotypic Vancomycin Susceptibility Test
A disk diffusion method was used for antibiotic susceptibility testing [10] . Trypticase soy agar (TSA) plates (REMEL Laboratories, Lenexa, KS) were inoculated over the entire surface with a cotton-tipped applicator moistened in a MRS broth (Thermo Fisher) suspension of L. lactis 1A-1at a density of 10 7 CFU/ml (a 1:10 dilution of a 0.5 McFarland standard). The disks of vancomycin (30 g) were applied to inoculated TSA plates, which were incubated overnight at 30ºC. Inhibition zone sizes of suspected vancomycin resistance gene-containing isolates were compared with zone sizes of bacteria that were susceptible to 30 μg/ml vancomycin in broth culture and E. faecium ATCC 51559, which contains the vanA gene and is resistant to 30 μg/ml vancomycin [11] . Control organisms were as follows: Enterococcus faecalis ATCC 51299 contained the vanB gene, Enterococcus gallinarum ATCC 49573 was used for the vanC 1 gene, the vanC 2/3 genes were present in Enterococcus casseliflavus ATCC 25788, and no vancomycin resistance gene was present in Enterococcus faecalis ATCC 29212 [11] .
Curing of Episomally Encoded Antimicrobial Resistance
To determine if the resistance genes were carried by a plasmid, L. lactis 1A-1 was grown in MRS broth for 15 days in the presence of 10 g/ml acridine orange [12] . Following repeated exposure to the curing agent, the bacteria were diluted in MRS broth and spread on MRS agar plates. The isolated colonies were replica-plated with nitrocellulose filters (Schleicher and Schuell, Keene, NH) to MRS agar plates without and with 30 μg/ml vancomycin. Susceptible colonies were tested by PCR to verify loss of the vanA gene. The isolate sensitivity to antibiotics was examined by the disk diffusion method.
Mating Experiments
A filter mating technique [13] was used to assess whether L. lactis 1A-1 could transfer vancomycin resistance by conjugation to S. aureus ATCC 25923. Bacteria were grown overnight in brain-heart infusion (BHI) broth (REMEL Laboratories). Donor (L. lactis 1A-1) and recipient (S. aureus) cells were mixed at a one to one ratio and incubated at 30°C for four hours in BHI broth. The cells were collected by suction filtration onto 0.45 μm cellulose acetate filters (Millipore Corp., Bedford, MA) and the filters were placed onto trypticase soy agar plates containing 5% sheep blood and 6 g/ml vancomycin. The plates were incubated overnight at 37°C. Bacteria were recovered from the plates and filters by rinsing with BHI broth. Vancomycin-resistant colonies of the recipient S. aureus were subcultured on BHI agar containing 30 g/ml of vancomycin. DNA was isolated from resistant recipients and tested by PCR for the presence of vancomycin resistance genes for verification of resistance mechanism transfer.
Screening, Isolation, Cloning and Sequencing Analysis of Vancomycin Resistance Genes
Existing PCR methods were used for detection of genes encoding vancomycin resistance [11, 14] . Genomic DNA from the L. lactis and S. aureus isolates was isolated using the Wizard Genomic DNA isolation kit (Promega, Madison, WI) and plasmid DNA was isolated using the technique described by Anderson and McKay [15] . The vanA gene sequences on the plasmid DNA were isolated by PCR (forward primer: 5' -GGG AAA ACG ACA ATT GC-3', reverse primer: 5' -GTA CAA TGC GGC CGT TA-3') and the products were inserted into the Eco RI polylinker site of a pCR2.1-TOPO cloning vector, as described in the manufacturer's instructions (Invitrogen). E. coli DH5 cells (Invitrogen) were transformed with the recombinant plasmids. The inserted resistance genes were sequenced and gene sequences were submitted to GenBank BLAST searches [16] to determine if they were homologous to known resistance genes (i.e., vanA). The PCR analyses [11] were used to detect vanA, vanB, vanC 1 , and vanC 2/3 , and the fragments lengths of the PCR product bands on 2% agarose electrophoresis gels were compared with a 100 bp ladder (Invitrogen).
RESULTS
Antimicrobial Susceptibility
The L. lactis 1A-1 isolated from the competitive exclusion product was resistant to vancomycin (30 μg/ml), when examined by the disk diffusion assay and compared to susceptible bacteria ( Table 1 ). The isolate was also able to grow in Elliker broth containing 1500 μg/ml vancomycin. The S. aureus transconjugants also exhibited smaller zones of inhibition than the original recipient strain ( Table 1) . 
Mating Experiments
Conjugative transfer of high level vancomycin resistance from L. lactis 1A-1 to S. aureus ATCC 25923 (sensitive parent strain) was demonstrated in vitro. Five transconjugant clones were recovered that were resistant to 30 μg/ml of vancomycin, having inhibition disk zone diameters of 15 mm, compared with a 20 mm zone diameter of the wild type S. aureus.
Screening, Isolation, Cloning and Sequencing Analysis for Vancomycin Resistance Genes
The presence of the vanA vancomycin resistance gene was detected in L. lactis 1A-1 and the S. aureus transconjugant, but not the wild type S. aureus recipient strain by PCR (Fig. 1) . The nucleotide sequences of the vanA gene of L. lactis 1A-1 were 97% identical to those of the E. faecium strain F4/13 (54) in GenBank, according to a BLAST search (Accession no. EF206285.1). The L. lactis 1A-1 isolate and the S. aureus transconjugants also had vanB gene sequences detectable by PCR (Fig. 2) . The vanC 1 (Fig. 3) and vanC 2/3 ( Fig. 4) genes were also detected in L. lactis 1A-1 and the S. aureus transconjugant, but not in the recipient wild type S. aureus. The vanC 1 PCR product had 97% sequence identity with the vanC 1 gene from Enterococcus gallinarum (Accession no. AY786180.1). 
Curing of Episomally Encoded Antimicrobial Resistance
The acridine orange treatment yielded revertant S. aureus transconjugants at a rate of 86%. The reversion rate of L. lactis 1A-1 was 36%. As a control, E. faecium 51559 was also treated with acridine orange. It had a reversion rate of 93%. The ability to make the bacteria susceptible to vancomycin by acridine orange treatment suggests that vanA was present on episomal DNA in L. lactis 1A-1 and the S. aureus transconjugant. Plasmid-cured L. lactis 1A-1 and the plasmid-cured S. aureus transconjugant were more susceptible than the uncured clones, as shown with the disk diffusion assay ( Table 1) .
DISCUSSION
The purpose of using CE products in poultry agriculture is to increase food safety by decreasing the incidence of adult animals reaching the human food supply contaminated with food-borne pathogens, such as Salmonella enterica and Campylobacter jejuni. The documented ability of these products to competitively exclude food-borne pathogens is encouraging, but not if the CE bacteria themselves pose a food safety risk [5] . The scientific community is aware that antimicrobial drug resistance genes can be mobilized between bacterial species in the gastrointestinal tract [17] . The vancomycin-resistant enterococci (VRE), once thought to be exclusively a problem associated with the medical use of glycopeptide drugs [18] , are now being found in environmental sources that may contribute to the growing threat of VRE in and outside of the clinical setting [19] . CE products could contain VRE that transfer vancomycin resistance to other bacteria in the products during manufacture and to bacteria in the GI tracts of human poultry consumers. VRE have the ability to conjugatively transfer vancomycin resistance genes to Staphylococcus aureus in vitro [13] . Since S. aureus is a normal constituent of human microbiota, the presence of VRE in poultry may have the potential to transform S. aureus in the microbiota of consumers, essentially infecting them with this troublesome opportunistic pathogen.
In the present study, we found a vancomycin-resistant L. lactis in a commercial CE product that may have acquired the vanA gene from a VRE reported to be present in the CE product [20] . We confirmed that L. lactis 1A-1 contained a vanA gene on a high molecular weight plasmid. The vanA gene was conjugatively transferred to S. aureus in vitro, suggesting that this activity could occur in vivo in a human poultry consumer. We also observed PCR products of other vancomycin resistance genes that may have been transferred from L. lactis 1A-1 to S. aureus, including vanB, vanC 1 , and vanC 2/3 . These latter genes are associated with intermediate levels of resistance to vancomycin, while vanA is usually required for high resistance levels greater than 30 μg/ml [21] . In fact, L. lactis 1A-1 was resistant to extremely high concentrations, up to 1500 μg/ml. The vanA [22] , vanB 1/2 [23, 24] , vanC 1 , and vanC 2/3 [11] genes have been reported on different conjugative DNA elements from different species of bacteria. Detection of multiple vancomycin resistance genes on the same conjugatively transferred element is uncommon. The co-culture methods used to produce some CE products may promote higher rates of gene transfer than the GI tract environment. Several reports indicate that factors normally present in the diet and the GI tract environment may inhibit horizontal gene transfer events, making the risk of this phenomenon less than might be otherwise expected [18, 25, 26] .
The nature of lactococci and enterococci appears to be that they can pass genes to each other. Horizontal gene transfer rates of mobilizable plasmids from L. lactis to E. faecalis have been measured in the digestive tracts of gnotobiotic mice at 3-4 log 10 CFU/g feces [27] . Evidence also exists for the ability of lactococci to transfer genes to Enterobacteriaceae [28] , so it is unclear how widely L. lactiscontaminated poultry meat could spread vancomycin resistance genes in the GI tracts of human consumers.
CONCLUSION
In the present study, multiple vancomycin resistance genes were transmissible by a L. lactis isolate from a CE product to a typical S. aureus that could be present in the GI tract of a human consumer. From the results presented in this study, it seems prudent to be concerned about the presence of transferable vancomycin resistance genes in live microbial animal feedstuffs and human food additives that contain enterococci and lactococci.
